Skip to content
← Resources / Articles
Deal structure4 min read

Signing is not closing: the $115bn deal that will take 18 months to happen

Marvell agreed to buy Lumentum on 2 November 2026. It expects to complete in the first half of 2028. Everything that can go wrong in a transaction lives in that gap, and on a fixed exchange ratio, the seller carries the risk of it.

All M&A Research

Deal structure and process

Updated
Fibre optic cables patched into a network switch in a server rack.
Fibre optic cables patched into a network switch in a server rack.

Key takeaways

  • Marvell agreed to acquire Lumentum on 2 November 2026 at an implied enterprise value of $115bn, and expects to close in the first half of calendar 2028: roughly 18 months later.
  • The consideration is a fixed exchange ratio of 4.500 Marvell shares per Lumentum share, so what a Lumentum holder actually receives moves with Marvell's share price for the whole of that period.
  • Completion depends on both sets of stockholders approving, on regulatory clearances, and on customary closing conditions. None of those were satisfied on the day it was announced.
  • In a private sale the gap is shorter but the structure is identical: signed is not paid, and the terms that govern the gap are worth more attention than the headline price.

On 2 November 2026 Marvell Technology agreed to acquire Lumentum Holdings. The announcement put the implied enterprise value at $115 billion, which made it one of the largest technology transactions ever signed, and the coverage treated it accordingly.

Read the announcement again and a different sentence stands out. The transaction is “expected to close in the first half of calendar year 2028”. The deal was agreed in November 2026. On the company’s own estimate, roughly eighteen months will pass between the handshake and the money.

That interval is the most under-examined part of any transaction, and it exists in every deal, at every size. It is shorter in a private sale, weeks or months rather than years, but it is the same gap, governed by the same kind of terms, and it is where deals are lost.

What has and has not happened on signing day

It is worth being precise about what an agreed deal actually is. According to the announcement, completion is “subject to approval by Marvell and Lumentum stockholders, receipt of regulatory approvals” and “other customary closing conditions.”

So on the day the deal was announced:

  • Neither company’s shareholders had voted on it.
  • No competition authority anywhere had cleared it.
  • The customary closing conditions (the representations still being true, no material adverse change, the financing being in place) had not been tested, because they are tested at completion, not at signature.

M&A News tracks this deal with the status Agreed, which is exactly right and is not the same as done. On the same tracker you will find transactions sitting at In review for the better part of a year, and some that move from Agreed to Terminated without ever closing.

The fixed exchange ratio moves the risk

The structure here is worth understanding because it is the clearest possible illustration of who carries what.

Lumentum stockholders will receive “a fixed exchange ratio of 4.500 shares of Marvell common stock for each share of Lumentum common stock.” At announcement that represented approximately $1,132 per Lumentum share, a premium of about 23.9% on each company’s unaffected closing price as of 28 October 2026. On completion, Marvell stockholders will own roughly 67% of the combined company on a fully diluted basis and Lumentum stockholders roughly 33%.

The word doing the work is fixed. The number of Marvell shares is settled; their value is not. If Marvell’s shares fall materially between now and the first half of 2028, the $1,132 headline falls with them, and a Lumentum holder has no recourse: they agreed to a quantity of shares, not an amount of money.

A fixed exchange ratio is not a price. It is a quantity, dressed as a price, for as long as it takes the deal to close.

The alternative, a floating ratio, which adjusts the share count to deliver a fixed value, moves that risk back onto the buyer. Which one you get is a negotiated point, and in a stock deal it matters more than almost anything else in the agreement.

The same gap, in a private sale

Nobody selling a private company will wait eighteen months. But the gap is there, and the questions it raises are the same ones:

  • Is any of the consideration deferred, and on what? Deferred cash, loan notes or an earn-out all mean you are a creditor of the buyer after completion, not a seller who has been paid.
  • What can the buyer walk away from, and until when? Material adverse change clauses, financing conditions and regulatory conditions are all exits. Know which ones exist and how long they stay open.
  • Who runs the business in the meantime? Covenants between signing and completion typically restrict what you can do without the buyer’s consent: hiring, capital spending, pricing, new contracts. You still carry the risk of the business while having less freedom to run it.
  • What happens to the balance sheet in the gap? Cash generated, working capital movements and debt paid down between signing and completion all have to be accounted for. This is the mechanical reason the working capital peg exists.

A seller who has thought about those four questions before going to market will negotiate a better agreement than one who first encounters them in a draft at eleven o’clock at night.

The point

Marvell and Lumentum have signed one of the largest technology deals in history, and on their own timetable nothing will actually change hands until 2028. The announcement is real and the intention is real. The transaction is not finished.

Treat your own deal the same way. The day you sign is not the day you have sold; it is the day you have agreed the terms on which you might. Everything between the two is governed by clauses that are negotiated when nobody is paying attention to them, because the price has already been agreed and everyone wants to go home.

Sources

  • Lumentum Holdings Inc., Current Report on Form 8-K, Exhibit 99.1 (announcement press release), filed November 2026. The exchange ratio of 4.500 Marvell shares per Lumentum share, implied enterprise value of $115 billion, approximately $1,132 per Lumentum share, premium of approximately 23.9% to unaffected closing prices as of 28 October 2026, pro forma ownership of approximately 67% / 33%, expected closing in the first half of calendar year 2028, and the conditions to completion.
  • Deal status and value as tracked by M&A News.